RC18 in Patients With Relapsing Remitting Multiple Sclerosis：a Phase II Trial
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04625153 |
|
Recruitment Status :
Recruiting
First Posted : November 12, 2020
Last Update Posted : January 11, 2022
|
Sponsor:
RemeGen Co., Ltd.
Information provided by (Responsible Party):
RemeGen Co., Ltd.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | April 2022 |
| Estimated Study Completion Date : | November 2022 |